VMP 36029411000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Octreotide 100micrograms/1ml solution for injection ampoules
BNF code 0803043N0AAABAB
Virtual Therapeutic Moiety Octreotide
Date identifier became valid 29 Oct 2018
Previous product identifier 327341008
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 9 Jun 2004
Previous name Octreotide 100micrograms/ml injection 1ml ampoules
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units ml
Unit dose unit of measure ampoule
Virtual Product Ingredient
Ingredient Octreotide acetate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 109053000
Strength value numerator 100.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninjection.subcutaneous
Ontology Drug Form & Route
Form & Route solutioninjection.intravenous
Dose Form
Formulation Solution for injection
Drug Route
Route Subcutaneous
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Octreotide 100micrograms/1ml solution for injection ampoules (Sandoz Ltd)
Octreotide 100micrograms/1ml solution for injection ampoules (Sun Pharmaceutical Industries Europe B.V.)
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd)
Sandostatin 100micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Octreotide 100micrograms/1ml solution for injection ampoules 5 ampoule

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback